03 · BROWSE
The corpus
Cached, sourced research units. Search semantically or filter by theme.
Latest GLP-1 / GIP / Glucagon Multi-Agonist Trial Results, Early 2026
$0.0250 · standard
Summary of recent (late 2025 – early 2026) trial readouts for incretin-based metabolic drugs — retatrutide, ecnoglutide, mazdutide, MariTide. Efficacy, safety, and how they compare to semaglutide / tirzepatide.
Best EV Charging Network for US Road Trips, 2026
$0.0100 · standard
Practical comparison of EV fast-charging networks for cross-country US travel — coverage, reliability, pricing, and Tesla NACS adapter compatibility for non-Tesla EVs.
Authorization: Bearer ck_… to fetch full unit content; balance is debited per call.